TRAVERE THERAPEUTICS INC. - COMMON STOCK
19.73
14-三月-25 16:45:00
15 分钟延时
股票
+0.60
+3.14%
今日范围
18.86 - 19.87
ISIN
N/A
来源
NASDAQ
-
25 8月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
22 8月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 8月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Second Quarter 2022 Financial Results
04 8月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Provides Regulatory Updates on its Development Programs
03 8月 2022 16:05:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report Second Quarter 2022 Financial Results
28 7月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 7月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 6月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the 2022 Jefferies Healthcare Conference
02 6月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Presentations of Abstracts at the 59th ERA Congress
17 5月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
16 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 5月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports First Quarter 2022 Financial Results
05 5月 2022 16:01:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Present at the BofA Securities 2022 Healthcare Conference
03 5月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics to Report First Quarter 2022 Financial Results
28 4月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Announces Plan for Chief Financial Officer Transition
20 4月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 4月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
21 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 3月 2022 17:00:00 条件 Nasdaq GlobeNewswire